Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:891-895

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, B. R.
Right arrow Articles by Watt, G. C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, B. R.
Right arrow Articles by Watt, G. C. M.

(Hypertension. 1998;31:891-895.)
© 1998 American Heart Association, Inc.


Rapid Communication

Increased Glucocorticoid Activity in Men With Cardiovascular Risk Factors

Brian R. Walker; David I.W. Phillips; Joseph P. Noon; Maurizio Panarelli; Ruth Andrew; Hugh V. Edwards; David W. Holton; Jonathan R. Seckl; David J. Webb; ; Graham C. M. Watt

From the University of Edinburgh, Department of Medicine, Western General Hospital (B.R.W., J.P.N., M.P., R.A., J.R.S., D.J.W.), and Ladywell Medical Centre (H.V.E., D.W.H.), Edinburgh; the MRC Environmental Epidemiology Unit, Southampton General Hospital, Southampton (D.I.W.P.); and the University of Glasgow, Department of General Practice, Woodside Health Centre, Glasgow (G.C.M.W.), UK.

Abstract

Abstract—The association between hypertension and insulin resistance might be explained by increased activity of the principal glucocorticoid, cortisol. Recent data show that the intensity of dermal vasoconstriction after topical application of glucocorticoids is increased in patients with essential hypertension. In this report, we examine whether increased glucocorticoid sensitivity or secretion is associated with insulin resistance and is a cause or consequence of hypertension. We studied 32 men (aged 47 to 56 years) from a cross-sectional study and 105 men (aged 23 to 33 years) in whom predisposition to high blood pressure has been defined by their own blood pressure and the blood pressures of their parents. In both populations, increased dermal glucocorticoid sensitivity was associated with relative hypertension, insulin resistance, and hyperglycemia. In young men with higher blood pressure whose parents also had high blood pressure, enhanced glucocorticoid sensitivity was accompanied by enhanced secretion of cortisol, enhanced ligand-binding affinities for dexamethasone in leukocytes, and impaired conversion of cortisol to inactive metabolites (cortisone and 5ß-dihydrocortisol). Increased tissue sensitivity to cortisol, amplified by enhanced secretion of cortisol, is a feature of the familial predisposition to high blood pressure rather than a secondary effect of high blood pressure. It may be mediated by an abnormal glucocorticoid receptor, and it may contribute to the association between hypertension and insulin resistance.


Key Words: receptors, corticosteroid • adrenal cortex hormones • blood pressure • insulin • blood vessels




This article has been cited by other articles:


Home page
Psychosom. Med.Home page
G. J. Molloy, L. Perkins-Porras, P. C. Strike, and A. Steptoe
Type-D Personality and Cortisol in Survivors of Acute Coronary Syndrome
Psychosom Med, October 1, 2008; 70(8): 863 - 868.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Puthanveetil, F. Wang, G. Kewalramani, M. S. Kim, E. Hosseini-Beheshti, N. Ng, W. Lau, T. Pulinilkunnil, M. Allard, A. Abrahani, et al.
Cardiac glycogen accumulation after dexamethasone is regulated by AMPK
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1753 - H1762.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
D. P Macfarlane, S. Forbes, and B. R Walker
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
J. Endocrinol., May 1, 2008; 197(2): 189 - 204.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
V. F. Panoulas, K. M. J. Douglas, A. Stavropoulos-Kalinoglou, G. S. Metsios, P. Nightingale, M. D. Kita, M. S. Elisaf, and G. D. Kitas
Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis
Rheumatology, January 1, 2008; 47(1): 72 - 75.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. R Walker
Glucocorticoids and Cardiovascular Disease
Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Chamarthi, N. S. Kolatkar, S. C. Hunt, J. S. Williams, E. W. Seely, N. J. Brown, L. J. Murphey, X. Jeunemaitre, and G. H. Williams
Urinary Free Cortisol: An Intermediate Phenotype and a Potential Genetic Marker for a Salt-Resistant Subset of Essential Hypertension
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1340 - 1346.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Hodroj, L. Legedz, N. Foudi, C. Cerutti, M.-C. Bourdillon, P. Feugier, M. Beylot, J. Randon, and G. Bricca
Increased Insulin-Stimulated Expression of Arterial Angiotensinogen and Angiotensin Type 1 Receptor in Patients With Type 2 Diabetes Mellitus and Atheroma
Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 525 - 531.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. R. Dover, P. W. F. Hadoke, L. J. Macdonald, E. Miller, D. E. Newby, and B. R. Walker
Intravascular Glucocorticoid Metabolism during Inflammation and Injury in Mice
Endocrinology, January 1, 2007; 148(1): 166 - 172.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. al'Absi, C. France, A. Harju, J. France, and L. Wittmers
Adrenocortical and nociceptive responses to opioid blockade in hypertension-prone men and women.
Psychosom Med, March 1, 2006; 68(2): 292 - 298.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. Terzolo, S. Bovio, A. Pia, P. A. Conton, G. Reimondo, C. Dall'Asta, D. Bemporad, A. Angeli, G. Opocher, M. Mannelli, et al.
Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma
Eur. J. Endocrinol., August 1, 2005; 153(2): 307 - 315.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
R. M Reynolds, B. R Walker, H. E Syddall, R. Andrew, P. J Wood, and D. I W Phillips
Is there a gender difference in the associations of birthweight and adult hypothalamic-pituitary-adrenal axis activity?
Eur. J. Endocrinol., February 1, 2005; 152(2): 249 - 253.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. Wei, T. M. MacDonald, and B. R. Walker
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Ann Intern Med, November 16, 2004; 141(10): 764 - 770.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Nakamura, M. Yoshimura, M. Nakayama, T. Ito, Y. Mizuno, E. Harada, T. Sakamoto, Y. Saito, K. Nakao, H. Yasue, et al.
Possible Association of Heart Failure Status With Synthetic Balance Between Aldosterone and Dehydroepiandrosterone in Human Heart
Circulation, September 28, 2004; 110(13): 1787 - 1793.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P C Souverein, A Berard, T P Van Staa, C Cooper, A C G Egberts, H G M Leufkens, and B R Walker
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study
Heart, August 1, 2004; 90(8): 859 - 865.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Qi, T. Pulinilkunnil, D. An, S. Ghosh, A. Abrahani, J. A. Pospisilik, R. Brownsey, R. Wambolt, M. Allard, and B. Rodrigues
Single-Dose Dexamethasone Induces Whole-Body Insulin Resistance and Alters Both Cardiac Fatty Acid and Carbohydrate Metabolism
Diabetes, July 1, 2004; 53(7): 1790 - 1797.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
A. Steptoe, J. Siegrist, C. Kirschbaum, and M. Marmot
Effort--Reward Imbalance, Overcommitment, and Measures of Cortisol and Blood Pressure Over the Working Day
Psychosom Med, May 1, 2004; 66(3): 323 - 329.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. C. Andrews, O. Herlihy, D. E. W. Livingstone, R. Andrew, and B. R. Walker
Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5587 - 5593.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E.J. Brunner, H. Hemingway, B.R. Walker, M. Page, P. Clarke, M. Juneja, M.J. Shipley, M. Kumari, R. Andrew, J.R. Seckl, et al.
Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome: Nested Case-Control Study
Circulation, November 19, 2002; 106(21): 2659 - 2665.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
B. M. Mitchell and R. C. Webb
Impaired Vasodilation and Nitric Oxide Synthase Activity in Glucocorticoid-Induced Hypertension
Biol Res Nurs, July 1, 2002; 4(1): 16 - 21.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. J. Irving, M. N. Carson, D. J. Webb, and B. R. Walker
Peripheral Vascular Structure and Function in Men with Contrasting GH Levels
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3309 - 3314.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. M. Reynolds, K. E. Chapman, J. R. Seckl, B. R. Walker, P. M. McKeigue, and H. O. Lithell
Skeletal Muscle Glucocorticoid Receptor Density and Insulin Resistance
JAMA, May 15, 2002; 287(19): 2505 - 2506.
[Full Text] [PDF]


Home page
DiabetesHome page
C. B. Whorwood, S. J. Donovan, D. Flanagan, D. I.W. Phillips, and C. D. Byrne
Increased Glucocorticoid Receptor Expression in Human Skeletal Muscle Cells May Contribute to the Pathogenesis of the Metabolic Syndrome
Diabetes, April 1, 2002; 51(4): 1066 - 1075.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
C. E Bertram and M. A Hanson
Animal models and programming of the metabolic syndrome: Type 2 diabetes
Br. Med. Bull., November 1, 2001; 60(1): 103 - 121.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
C. D Byrne
Programming other hormones that affect insulin: Type 2 diabetes
Br. Med. Bull., November 1, 2001; 60(1): 153 - 171.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
R.J. Irving, J.P. Noon, G.C.M. Watt, D.J. Webb, and B.R. Walker
Activation of the endothelin system in insulin resistance
QJM, June 1, 2001; 94(6): 321 - 326.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. B. Whorwood, S. J. Donovan, P. J. Wood, and D. I. W. Phillips
Regulation of Glucocorticoid Receptor {{alpha}} and {beta} Isoforms and Type I 11{beta}-Hydroxysteroid Dehydrogenase Expression in Human Skeletal Muscle Cells: A Key Role in the Pathogenesis of Insulin Resistance?
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2296 - 2308.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. M. Reynolds, B. R. Walker, H. E. Syddall, C. B. Whorwood, P. J. Wood, and D. I. W. Phillips
Elevated Plasma Cortisol in Glucose-Intolerant Men: Differences in Responses to Glucose and Habituation to Venepuncture
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1149 - 1153.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. M. Reynolds, B. R. Walker, H. E. Syddall, R. Andrew, P. J. Wood, C. B. Whorwood, and D. I. W. Phillips
Altered Control of Cortisol Secretion in Adult Men with Low Birth Weight and Cardiovascular Risk Factors
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 245 - 250.
[Abstract] [Full Text]


Home page
HypertensionHome page
J. A. Whitworth, G. J. Mangos, and J. J. Kelly
Cushing, Cortisol, and Cardiovascular Disease
Hypertension, November 1, 2000; 36(5): 912 - 916.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Ebrecht, A. Buske-Kirschbaum, D. Hellhammer, S. Kern, N. Rohleder, B. Walker, and C. Kirschbaum
Tissue Specificity of Glucocorticoid Sensitivity in Healthy Adults
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3733 - 3739.
[Abstract] [Full Text]


Home page
IOVSHome page
J. Stokes, J. Noble, L. Brett, C. Phillips, J. R. Seckl, C. O’Brien, and R. Andrew
Distribution of Glucocorticoid and Mineralocorticoid Receptors and 11{beta}-Hydroxysteroid Dehydrogenases in Human and Rat Ocular Tissues
Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1629 - 1638.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. C. Y. Lin, W. Y. S. Wang, and B. J. Morris
Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension
Hypertension, December 1, 1999; 34(6): 1186 - 1192.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Lovati, P. Ferrari, B. Dick, K. Jostarndt, B. M. Frey, F. J. Frey, U. Schorr, and A. M. Sharma
Molecular Basis of Human Salt Sensitivity: The Role of the 11{beta}-Hydroxysteroid Dehydrogenase Type 2
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3745 - 3749.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Fraser, M. C. Ingram, N. H. Anderson, C. Morrison, E. Davies, and J. M. C. Connell
Cortisol Effects on Body Mass, Blood Pressure, and Cholesterol in the General Population
Hypertension, June 1, 1999; 33(6): 1364 - 1368.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Takami, Z. Y. H. Wong, M. Stebbing, and S. B. Harrap
Linkage analysis of glucocorticoid and beta 2-adrenergic receptor genes with blood pressure and body mass index
Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1379 - H1384.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Christ and M. Wehling
Cardiovascular steroid actions: swift swallows or sluggish snails?
Cardiovasc Res, October 1, 1998; 40(1): 34 - 44.
[Abstract] [Full Text] [PDF]